Inhibrx Biosciences, Inc. Share Price Today: Live Updates & Key Insights

Inhibrx Biosciences, Inc. share price today is $61.04, up -6.09%. The stock opened at $63.88 against the previous close of $64.87, with an intraday high of $63.88 and low of $60.94.

Inhibrx Biosciences, Inc. Share Price Chart

Inhibrx Biosciences, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Inhibrx Biosciences, Inc. Share Price Performance

$61.04 -0.0609(-6.09%) INBX at 23 Mar 2026 01:39 PM Biotechnology
Lowest Today 60.94
Highest Today 63.88
Today’s Open 63.88
Prev. Close 64.87
52 Week High 94.57
52 Week Low 10.81
Day’s Range: Low 60.94 High 63.88
52-Week Range: Low 10.81 High 94.57
1 day return -
1 Week return -11.94
1 month return -20.43
3 month return -30.43
6 month return +125.07
1 year return +313.83
3 year return -
5 year return -
10 year return -

Inhibrx Biosciences, Inc. Institutional Holdings

Inhibrx Biosciences, Inc. Market Status

Inhibrx Biosciences, Inc. Fundamentals

Market Cap 886.00 M

PB Ratio 25.5769

PE Ratio 0.0

Enterprise Value 897.27 M

Total Assets 146.48 M

Volume 680559

Inhibrx Biosciences, Inc. Company Financials

Annual Revenue FY23:440000 0.4M, FY22:2178000 2.2M, FY21:7125000 7.1M, FY20:12808000 12.8M, FY19:9093000 9.1M

Annual Profit FY23:null 0.0M, FY22:2178000 2.2M, FY21:7125000 7.1M, FY20:12808000 12.8M, FY19:9093000 9.1M

Annual Net worth FY23:-188672000 -188.7M, FY22:-145226000 -145.2M, FY21:-81768000 -81.8M, FY20:-75637000 -75.6M, FY19:-51400000 -51.4M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:1300000 1.3M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:100000 0.1M

Quarterly Profit Q3/2025:-582000 -0.6M, Q2/2025:638000 0.6M, Q1/2025:-675000 -0.7M, Q3/2024:null 0.0M, Q2/2024:-375000 -0.4M

Quarterly Net worth Q3/2025:-35256000 -35.3M, Q2/2025:-28654000 -28.7M, Q1/2025:-43311000 -43.3M, Q3/2024:-43864000 -43.9M, Q2/2024:1858011000 1858.0M

About Inhibrx Biosciences, Inc. & investment objective

Company Information Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.

Organisation Biotechnology

Employees 109

Industry Biotechnology

CEO Mr. Mark Paul Lappe

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Inhibrx Biosciences, Inc. FAQs

What is the share price of Inhibrx Biosciences, Inc. today?

The current share price of Inhibrx Biosciences, Inc. is $61.04.

Can I buy Inhibrx Biosciences, Inc. shares in India?

Yes, Indian investors can buy Inhibrx Biosciences, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Inhibrx Biosciences, Inc. shares in India?

You can easily invest in Inhibrx Biosciences, Inc. shares from India by:

Can I buy fractional shares of Inhibrx Biosciences, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. has a market cap of $886.00 M.

In which sector does Inhibrx Biosciences, Inc. belong?

Inhibrx Biosciences, Inc. operates in the Biotechnology sector.

What documents are required to invest in Inhibrx Biosciences, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Inhibrx Biosciences, Inc.?

The PE ratio of Inhibrx Biosciences, Inc. is N/A and the PB ratio is 25.58.